Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

OBJECTIVE: This study was to investigate the feasibility and safety of anlotinib monotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC) retrospectively. METHODS: This study was designed as a real-world study. A total of 83 patients with advanced or metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Song, Wang, Xin, Gu, Hao, Liu, Jun-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113659/
https://www.ncbi.nlm.nih.gov/pubmed/35592110
http://dx.doi.org/10.2147/CMAR.S359482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113659/
https://www.ncbi.nlm.nih.gov/pubmed/35592110
http://dx.doi.org/10.2147/CMAR.S359482

Ejemplares similares